Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 3,770.00
-50.00 (-1.31%)
Jul 1, 2026, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 46.59 billion as of June 30, 2026. Its market cap has decreased by -70.20% in one year.
Market Cap
46.59B
Enterprise Value
27.74B
Revenue
475.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,770.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has decreased from 106.25B to 46.59B, a decrease of -56.15%. That is a compound annual growth rate of -41.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 46.59B | -59.57% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcell-Bio Therapeutics | 119.54B |
| MedPacto | 109.34B |
| Amicogen | 107.58B |
| ENCell | 90.11B |
| iNtRON Biotechnology | 82.99B |
| Prestige BioPharma | 81.01B |
| CG Invites | 76.89B |
| ORIENT BIO | 51.52B |